Penn State Health Eye Center research is critical in providing the best possible patient care. Faculty from many departments participate in both clinical and basic research to improve treatments for diseases such as age-related macular degeneration, pediatric eye disease, diabetic retinopathy, retinal vein occlusion and corneal wound healing.
Penn State Health Eye Center is dedicated to supporting cutting edge research that translates to the provision of up-to-date eye care treatments for our patients in central Pennsylvania and beyond.
Learn More About Ophthalmology
Penn State faculty participate in several national clinical research studies through the National Eye Institute of the National Institutes of Health.
Current study topics in ophthalmology include:
- Inherited retinal degeneration
- Early non-invasive ocular markers for diabetic complications
- Establishment of a biorepository of ocular tissue and vitreous fluid for future study
- The safety and efficacy of various compounds in patients with neovascular age-related macular degeneration
Penn State researchers have identified key pathways to stimulate healing of the cornea after injuries.
Through their National Eye Institute grant, they discovered that drugs controlling the opioid growth factor system can accelerate wound healing in the cornea. This approach may be particularly helpful for people with diabetes or recurrent corneal erosions.
The Penn State Retina Research Labs continue basic research in vision loss due to diabetic retinopathy. With funding from the National Eye Institute, the Juvenile Diabetes Research Foundation, the American Diabetes Association and Lions Clubs International, they are developing and testing new treatments to counteract vision loss in diabetes.
Alistair Barber, PhD, is Associate Research Director of the Penn State Health Eye Center.